NCT03623243 · Interventional trial
Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS Patients
Overall registry status Completed
Phase 3
Conditions Advancing Multiple Sclerosis, Multiple Sclerosis, Relapsing Multiple Sclerosis
Delaware Valley sites
- Abington Neurological Associates, Ltd · Abington, PA · Montgomery County
- Novartis Investigative Site · Philadelphia, PA · Philadelphia County
- Novartis Investigative Site · Willow Grove, PA · Montgomery County
First posted
Registry updated
Added to the directory